Reata Pharmaceuticals News - RETA

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Reata Pharmaceuticals Inc RETA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.22 -0.12% 184.69 189.39 182.48 185.25 184.91 09:39:37
more quote information »

Recent News

Date Time Source Heading
10/17/201916:52EDGARStatement of Changes in Beneficial Ownership (4)
10/16/201916:24EDGARCurrent Report Filing (8-k)
10/15/201916:04EDGARStatement of Changes in Beneficial Ownership (4)
10/15/201915:53EDGARStatement of Changes in Beneficial Ownership (4)
10/15/201906:48EDGARCurrent Report Filing (8-k)
10/14/201916:01GLOBEReata Announces Positive Topline Results from the MOXIe..
10/11/201916:47EDGARStatement of Changes in Beneficial Ownership (4)
10/11/201910:00GLOBEReata Pharmaceuticals, Inc. Announces Presentations at the..
10/10/201912:41DJNReata Pharmaceuticals Shares Up 8% on Re-Acquiring..
10/10/201907:49DJNReata Pharmaceuticals Reacquires Rights to Bardoxolne
10/10/201906:52EDGARCurrent Report Filing (8-k)
10/10/201906:45GLOBEReata Pharmaceuticals Reacquires Rights From AbbVie to..
9/30/201915:19EDGARStatement of Changes in Beneficial Ownership (4)
9/25/201914:09EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
9/13/201912:27EDGARStatement of Changes in Beneficial Ownership (4)
9/10/201915:46EDGARStatement of Changes in Beneficial Ownership (4)
8/29/201916:21EDGARStatement of Changes in Beneficial Ownership (4)
8/29/201916:17EDGARInitial Statement of Beneficial Ownership (3)
8/29/201906:01EDGARCurrent Report Filing (8-k)
8/28/201916:01GLOBEReata Appoints Manmeet S. Soni as Chief Financial Officer;..
8/22/201916:55EDGARCurrent Report Filing (8-k)
8/16/201915:09EDGARStatement of Changes in Beneficial Ownership (4)
8/08/201906:51EDGARQuarterly Report (10-q)
8/08/201906:45EDGARCurrent Report Filing (8-k)
8/08/201906:40GLOBEReata Pharmaceuticals, Inc. Announces Second Quarter 2019..
8/01/201906:45GLOBEReata Pharmaceuticals, Inc. to Report Second Quarter 2019..
7/17/201913:02EDGARStatement of Changes in Beneficial Ownership (4)
6/19/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
6/14/201915:03EDGARStatement of Changes in Beneficial Ownership (4)
6/14/201914:19EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201917:07EDGARSecurities Registration: Employee Benefit Plan (s-8)
6/13/201916:14EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201916:09EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201916:06EDGARCurrent Report Filing (8-k)
6/13/201916:05EDGARStatement of Changes in Beneficial Ownership (4)
6/05/201918:00GLOBEReata Pharmaceuticals, Inc. Receives Orphan Drug Designation..
6/05/201913:12EDGARStatement of Changes in Beneficial Ownership (4)
6/04/201919:00GLOBEReata Announces Presentations at the 56th Congress of the..
5/30/201906:45GLOBEReata Announces First Patient Enrolled in Phase 3 FALCON..
5/17/201911:48EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201906:57EDGARQuarterly Report (10-q)
5/09/201906:50EDGARCurrent Report Filing (8-k)
5/09/201906:45GLOBEReata Pharmaceuticals, Inc. Announces First Quarter 2019..
5/02/201916:15GLOBEReata Announces Presentation at the Annual CKD3 Chronic..
5/02/201906:45GLOBEReata Pharmaceuticals, Inc. to Report First Quarter 2019..
4/30/201906:51EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/30/201906:28EDGARProxy Statement (definitive) (def 14a)
4/16/201914:21EDGARStatement of Changes in Beneficial Ownership (4)
4/09/201917:25EDGARStatement of Changes in Beneficial Ownership (4)
3/21/201915:25EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NASDAQ
RETA
Reata Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.